Extraction, chemical analysis, and formulation development of potential anti-viral plant isolates against SARS-CoV-2

The COVID-19 pandemic has had broad global ramifications and preventative strategies and treatments for the virus are crucial. PBG BioPharma has developed two plant-based isolates, PBG-005 & PBG-007, that have shown innate immunological properties, potentially usable in the treatment or prevention of multi-viral infections. This research proposes leveraging PBG-005 & PGB-007, as well as PBG’s newly-completed GMP-compliant manufacturing facility and laboratories, to develop, formulate, and product anti-viral products which may be effective in treating SARS-CoV-2. This project will not only assist PBG BioPharma in creating anti-viral formulation and products, which will in turn bring great economic benefits, but will also provide a potential method and treatment of SARS-CoV-2 directly or as an adjunct therapy under the current rapidly evolving epidemiological situatio

Faculty Supervisor:

Jie Chen

Student:

Dan Jin

Partner:

PBG BioPharma

Discipline:

Engineering - biomedical

Sector:

Manufacturing

University:

University of Alberta